Ikena Oncology™ discovers and develops patient-directed therapies for cancer patients who need life-saving treatment, by understanding what drives their disease.Learn More
Making it personal to change what’s possible.
Discovering and developing patient-directed therapies for cancer patients by understanding what drives their disease.Learn More
Pioneering Biomarker-Driven Oncology Therapeutics
Ikena™ is a targeted oncology company developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer.IKENA™ APPROACH
Pioneering Biomarker-Driven Oncology Therapeutics
Ikena™ is a targeted oncology company developing novel cancer therapies targeting key signaling pathways that drive cancer. IKENA™ APPROACH
Innovating for Our Patients
At Ikena, our pipeline includes targeted oncology and tumor microenvironment programs focused on genetically defined or biomarker-driven cancers.VIEW OUR PIPELINE
Innovating for Our Patients
Our pipeline includes targeted oncology and tumor microenvironment programs focused on genetically defined or biomarker-driven cancers.VIEW OUR PIPELINE
